Vimarsana
Biggest News Aggregation in the World

Page 17 - Key Challenges News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Key Challenges. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Key Challenges Today - Breaking & Trending Today

Direct to patient: the rocky road to remote drug delivery in clinical trials - Vimarsana News

Direct to patient: the rocky road to remote drug delivery in clinical trials

While an obvious solution to lockdown measures, direct-to-patient remote drug delivery is still an untapped opportunity in clinical trials.

Middle East & Africa's pharma industry IT hiring activity drops 17.1% in December 2021 - Vimarsana News

Middle East & Africa's pharma industry IT hiring activity drops 17.1% in December 2021

Middle East & Africa witnessed a 17.1% drops in IT hiring activity in the pharma industry in December 2021, according to GlobalData’s Job Analytics index

 - Vimarsana News

The following discussion and analysis should be read in conjunction with our unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this... | February 4, 2022

NorthSea begins intestinal failure associated liver disease therapy trial - Vimarsana News

NorthSea begins intestinal failure associated liver disease therapy trial

NorthSea Therapeutics has commenced a Phase I trial of SEFA-6179 in adult subjects, to obtain a preliminary orphan indication to treat IFALD.

FDA grants clearance to begin Viridian's thyroid eye disease antibody trial - Vimarsana News

FDA grants clearance to begin Viridian's thyroid eye disease antibody trial

The US FDA cleared IND application of Viridian Therapeutics to commence Phase I trial of its antibody VRDN-002 to treat thyroid eye disease.